Abstract: Stem cell-based therapies for stroke have expanded substantially over the last decade. The diversity of embryonic and adult tissue sources provides researchers with the ability to harvest an ample supply of stem cells. However, the optimal conditions of stem cell use are still being determined. Along this line of the need for optimization studies, we discuss studies that demonstrate effective dose, timing, and route of stem cells. We recognize that stem cell derivations also provide uniquely individual difficulties and limitations in their therapeutic applications. This review will outline the current knowledge, including benefits and challenges, of the many current sources of stem cells for stroke therapy.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Shinozuka, K.; Dailey, T.; Tajiri, N.; Ishikawa, H.; Kaneko, Y.; Borlongan, C.V. Stem Cell Transplantation for Neuroprotection in Stroke. Brain Sci. 2013, 3, 239-261.
Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV. Stem Cell Transplantation for Neuroprotection in Stroke. Brain Sciences. 2013; 3(1):239-261.
Shinozuka, Kazutaka; Dailey, Travis; Tajiri, Naoki; Ishikawa, Hiroto; Kaneko, Yuji; Borlongan, Cesar V. 2013. "Stem Cell Transplantation for Neuroprotection in Stroke." Brain Sci. 3, no. 1: 239-261.